Bank of America’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
1,202,513
+687,562
| +134% | +$9.64M | ﹤0.01% | 2364 |
|
|
2025
Q1 | $8.05M | Sell |
514,951
-21,507
| -4% | -$336K | ﹤0.01% | 2852 |
|
|
2024
Q4 | $7.47M | Sell |
536,458
-639,447
| -54% | -$8.91M | ﹤0.01% | 2723 |
|
|
2024
Q3 | $10.9M | Buy |
1,175,905
+608,782
| +107% | +$5.66M | ﹤0.01% | 2560 |
|
|
2024
Q2 | $5.27M | Sell |
567,123
-283,406
| -33% | -$2.64M | ﹤0.01% | 3060 |
|
|
2024
Q1 | $8.43M | Buy |
850,529
+759,511
| +834% | +$7.53M | ﹤0.01% | 2674 |
|
|
2023
Q4 | $294K | Sell |
91,018
-259,945
| -74% | -$840K | ﹤0.01% | 4954 |
|
|
2023
Q3 | $1.86M | Sell |
350,963
-55,592
| -14% | -$295K | ﹤0.01% | 3604 |
|
|
2023
Q2 | $3.87M | Sell |
406,555
-1,215,219
| -75% | -$11.6M | ﹤0.01% | 3068 |
|
|
2023
Q1 | $17.8M | Buy |
1,621,774
+1,382,736
| +578% | +$15.2M | ﹤0.01% | 1922 |
|
|
2022
Q4 | $3.54M | Buy |
239,038
+87,781
| +58% | +$1.3M | ﹤0.01% | 3200 |
|
|
2022
Q3 | $2.89M | Buy |
151,257
+112,962
| +295% | +$2.16M | ﹤0.01% | 3344 |
|
|
2022
Q2 | $816K | Buy |
38,295
+28,295
| +283% | +$603K | ﹤0.01% | 4403 |
|
|
2022
Q1 | $193K | Sell |
10,000
-2,110
| -17% | -$40.7K | ﹤0.01% | 5731 |
|
|
2021
Q4 | $251K | Buy |
12,110
+5,600
| +86% | +$116K | ﹤0.01% | 5558 |
|
|
2021
Q3 | $156K | Sell |
6,510
-23
| -0.4% | -$551 | ﹤0.01% | 5611 |
|
|
2021
Q2 | $178K | Sell |
6,533
-23,828
| -78% | -$649K | ﹤0.01% | 5398 |
|
|
2021
Q1 | $878K | Buy |
30,361
+25,356
| +507% | +$733K | ﹤0.01% | 4361 |
|
|
2020
Q4 | $141K | Buy |
5,005
+486
| +11% | +$13.7K | ﹤0.01% | 5087 |
|
|
2020
Q3 | $132K | Buy |
4,519
+743
| +20% | +$21.7K | ﹤0.01% | 4914 |
|
|
2020
Q2 | $114K | Sell |
3,776
-896
| -19% | -$27.1K | ﹤0.01% | 5045 |
|
|
2020
Q1 | $139K | Buy |
+4,672
| New | +$139K | ﹤0.01% | 4749 |
|